Stock Events

Stock Events

SanBio Company Limited 

$5.48
13
+$0.00+0% Friday 20:00

Statistics

Day High
2.81
Day Low
2.81
52W High
5.48
52W Low
2.81
Volume
211
Avg. Volume
0
Mkt Cap
427.62M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

14SepExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-0.15
-0.1
-0.05
0
Expected EPS
-0.030466350345
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-18.82MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SNBOY. It's not an investment recommendation.
AnGes
3
4563.TSE
Tesla
2
TSLA
JX Advanced Metals
2
5016.TSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap31B
Biogen Inc. focuses on the discovery, development, and delivery of therapies for neurological and neurodegenerative diseases, competing directly with SanBio's regenerative solutions for neurological conditions.
Novartis
NVS
Mkt Cap286.78B
Novartis AG operates in the pharmaceuticals sector, including treatments for neurological conditions similar to those targeted by SanBio, making it a direct competitor in the neurology healthcare market.
Pfizer
PFE
Mkt Cap152.69B
Pfizer Inc. is involved in the development and commercialization of medicines and vaccines, including for neurological diseases, competing with SanBio's offerings in the healthcare market.
Gilead Sciences
GILD
Mkt Cap171.56B
Gilead Sciences, Inc. focuses on the development of medicines in areas of unmet medical need, including neurological conditions, positioning it as a competitor to SanBio.
Merck
MRK
Mkt Cap335.14B
Merck & Co., Inc. provides healthcare solutions, including for neurological diseases, making it a competitor in the same therapeutic area as SanBio.
Rogers
ROG
Mkt Cap2.55B
Roche Holding AG engages in the pharmaceuticals and diagnostics business, including neurology and neurodegenerative diseases, directly competing with SanBio's focus areas.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie Inc. researches and develops pharmaceutical products, including for neurological disorders, competing in the same market as SanBio.
AMGEN
AMGN
Mkt Cap224.63B
Amgen Inc. focuses on areas of high unmet medical need, including neurology, which pits it against SanBio in the competition for treatments in this area.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly and Company is engaged in the discovery, development, and marketing of pharmaceutical products for neurological conditions, directly competing with SanBio.
Astrazeneca
AZN
Mkt Cap242.64B
AstraZeneca PLC operates in the biopharmaceutical industry, focusing on innovative medicines, including for neurological diseases, making it a competitor to SanBio.

About

SANBIO CO LTD UNSP/ADR
Show more...
CEO
Keita Mori
Country
Japan
ISIN
US7995731004

Listings

OTC Link
US
SNBIF
TSE
JP
4592.TSE
OTC Link
US
SNBOY

0 Comments

Share your thoughts

FAQ

What is SanBio Company Limited stock price today?▼
The current price of SNBOY is $5.48 USD — it has increased by +0% in the past 24 hours. Watch SanBio Company Limited stock price performance more closely on the chart.
What is SanBio Company Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange SanBio Company Limited stocks are traded under the ticker SNBOY.
What is SanBio Company Limited market cap?▼
Today SanBio Company Limited has the market capitalization of 427.62M
When is the next SanBio Company Limited earnings date?▼
SanBio Company Limited is going to release the next earnings report on September 14, 2026.
What were SanBio Company Limited earnings last quarter?▼
SNBOY earnings for the last quarter are -0.07 USD per share, whereas the estimation was -0.04 USD resulting in a -72.92% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is SanBio Company Limited revenue for the last year?▼
SanBio Company Limited revenue for the last year amounts to 0 USD.
What is SanBio Company Limited net income for the last year?▼
SNBOY net income for the last year is -18.82M USD.
In which sector is SanBio Company Limited located?▼
SanBio Company Limited operates in the Health & Wellness sector.
When did SanBio Company Limited complete a stock split?▼
SanBio Company Limited has not had any recent stock splits.
Where is SanBio Company Limited headquartered?▼
SanBio Company Limited is headquartered in Tokyo, Japan.